BioSpace News Archive

Agilvax, Inc. announced the receipt of a Fast Track Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI).

Synergy Pharmaceuticals Inc. announced that leading U.S. pharmacy benefit manager, Express Scripts, will add TRULANCE to its National Preferred Formulary List, effective January 1, 2019.

Establishing a Practical Road Map From the Intersect of Digital Health and Innovation

The Prescription Drug User Fee Act (PDUFA) target action date for completion of the FDA review is March 21, 2019

With the cost to provide health care benefits expected to approach $15,000 per employee next year, large U.S. employers are increasingly playing an activist role in changing the health care delivery system and reexamining existing models, according to an annual survey released today by the National Business Group on Health.

CFN Media Group announces publication of an article covering Emerald Health Therapeutics Inc.'s (TSX-V: EMH) (OTCQX: EMHTF) recent acquisition of a dealer license from Abattis Bioceuticals Corp. that enables it to compete in emerging market verticals.

Lyme ImmunoBlots (IgM and IgG) represents quantum leap in test performance over the traditional B. burgdorferi Western blots.

CeraShield™ resorbable envelope targets prevention of bacterial and highly lethal fungal infections and reduction of surgical site infections of pacemaker implantations

Realm’s management team will host a conference call and audio webcast at 9:00 a.m. ET / 2:00 p.m. BST on Tuesday, August 14, 2018 to discuss the financial results and recent operational highlights.

The 2018 Wedbush PacGrow Healthcare Conference on Tuesday, August 14, 2018, at 3:40 p.m. ET in New York, NY.